Razadyne and Pregnancy

In clinical studies on Razadyne and pregnancy, the medicine did not cause any problems when it was given to pregnant rabbits and rats. However, it is not known whether the drug is safe for use in pregnant humans. Since Razadyne is only approved for treating Alzheimer's disease, which generally occurs in elderly people, it is not likely that a pregnant woman would need to use Razadyne.

 

Razadyne During Pregnancy: An Overview

Razadyne® (galantamine hydrobromide) is a prescription medication approved to treat Alzheimer's disease. Animal studies indicate that Razadyne is probably safe for use during pregnancy.
 

Razadyne and Pregnancy Category B

The U.S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is given to medicines that have not been adequately studied in pregnant humans but do not appear to cause harm to the fetus in animal studies. In studies, Razadyne did not cause problems when given to pregnant rabbits and rats.
 
It is important to note that animals do not always respond to medicines the same way that humans do, and it may be possible that Razadyne could cause problems in pregnant humans. Therefore, a pregnancy Category B medicine should be given to a pregnant woman only if a healthcare provider believes that the benefits to the pregnant woman outweigh any possible risks to the unborn child. It is also important to note that Razadyne is approved only for the treatment of Alzheimer's disease, a disease that is not likely to occur in women of childbearing age.
 

Razadyne and Pregnancy: Final Thoughts

If you are pregnant or thinking about becoming pregnant, let your healthcare provider know. He or she will consider both the benefits and risks of taking Razadyne during pregnancy before making a recommendation for your particular situation.
 
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;